821 related articles for article (PubMed ID: 26222337)
1. Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation.
Lan T; Kisseleva T; Brenner DA
PLoS One; 2015; 10(7):e0129743. PubMed ID: 26222337
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.
Aoyama T; Paik YH; Watanabe S; Laleu B; Gaggini F; Fioraso-Cartier L; Molango S; Heitz F; Merlot C; Szyndralewiez C; Page P; Brenner DA
Hepatology; 2012 Dec; 56(6):2316-27. PubMed ID: 22806357
[TBL] [Abstract][Full Text] [Related]
3. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo.
Jiang JX; Chen X; Serizawa N; Szyndralewiez C; Page P; Schröder K; Brandes RP; Devaraj S; Török NJ
Free Radic Biol Med; 2012 Jul; 53(2):289-96. PubMed ID: 22618020
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of cannabinoid receptor-1 and fibrotic activation of mouse hepatic stellate cells during Schistosoma J. infection: role of NADPH oxidase.
Wang M; Abais JM; Meng N; Zhang Y; Ritter JK; Li PL; Tang WX
Free Radic Biol Med; 2014 Jun; 71():109-120. PubMed ID: 24657416
[TBL] [Abstract][Full Text] [Related]
5. The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice.
Paik YH; Iwaisako K; Seki E; Inokuchi S; Schnabl B; Osterreicher CH; Kisseleva T; Brenner DA
Hepatology; 2011 May; 53(5):1730-41. PubMed ID: 21384410
[TBL] [Abstract][Full Text] [Related]
6. NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development.
Sancho P; Mainez J; Crosas-Molist E; Roncero C; Fernández-Rodriguez CM; Pinedo F; Huber H; Eferl R; Mikulits W; Fabregat I
PLoS One; 2012; 7(9):e45285. PubMed ID: 23049784
[TBL] [Abstract][Full Text] [Related]
7. Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes.
Gorin Y; Cavaglieri RC; Khazim K; Lee DY; Bruno F; Thakur S; Fanti P; Szyndralewiez C; Barnes JL; Block K; Abboud HE
Am J Physiol Renal Physiol; 2015 Jun; 308(11):F1276-87. PubMed ID: 25656366
[TBL] [Abstract][Full Text] [Related]
8. NOX1/nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase promotes proliferation of stellate cells and aggravates liver fibrosis induced by bile duct ligation.
Cui W; Matsuno K; Iwata K; Ibi M; Matsumoto M; Zhang J; Zhu K; Katsuyama M; Torok NJ; Yabe-Nishimura C
Hepatology; 2011 Sep; 54(3):949-58. PubMed ID: 21618578
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and liver fibrosis: A review.
Mortezaee K
Cell Biochem Funct; 2018 Aug; 36(6):292-302. PubMed ID: 30028028
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine phosphatase 1b deficiency protects against hepatic fibrosis by modulating nadph oxidases.
García-Ruiz I; Blanes Ruiz N; Rada P; Pardo V; Ruiz L; Blas-García A; Valdecantos MP; Grau Sanz M; Solís Herruzo JA; Valverde ÁM
Redox Biol; 2019 Sep; 26():101263. PubMed ID: 31299613
[TBL] [Abstract][Full Text] [Related]
12. Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells.
De Minicis S; Seki E; Oesterreicher C; Schnabl B; Schwabe RF; Brenner DA
Hepatology; 2008 Dec; 48(6):2016-26. PubMed ID: 19025999
[TBL] [Abstract][Full Text] [Related]
13. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.
Jha JC; Gray SP; Barit D; Okabe J; El-Osta A; Namikoshi T; Thallas-Bonke V; Wingler K; Szyndralewiez C; Heitz F; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
J Am Soc Nephrol; 2014 Jun; 25(6):1237-54. PubMed ID: 24511132
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice.
Bettaieb A; Jiang JX; Sasaki Y; Chao TI; Kiss Z; Chen X; Tian J; Katsuyama M; Yabe-Nishimura C; Xi Y; Szyndralewiez C; Schröder K; Shah A; Brandes RP; Haj FG; Török NJ
Gastroenterology; 2015 Aug; 149(2):468-80.e10. PubMed ID: 25888330
[TBL] [Abstract][Full Text] [Related]
15.
Yan J; Hu B; Shi W; Wang X; Shen J; Chen Y; Huang H; Jin L
Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G720-G728. PubMed ID: 33728992
[TBL] [Abstract][Full Text] [Related]
16. β-Arrestin2 deficiency attenuates oxidative stress in mouse hepatic fibrosis through modulation of NOX4.
Du JJ; Sun JC; Li N; Li XQ; Sun WY; Wei W
Acta Pharmacol Sin; 2021 Jul; 42(7):1090-1100. PubMed ID: 33116250
[TBL] [Abstract][Full Text] [Related]
17. Exogenous 8-hydroxydeoxyguanosine ameliorates liver fibrosis through the inhibition of Rac1-NADPH oxidase signaling.
Shin SK; Kim KO; Kim SH; Kwon OS; Choi CS; Jeong SH; Kim YS; Kim JH; Chung MH
J Gastroenterol Hepatol; 2020 Jun; 35(6):1078-1087. PubMed ID: 31907970
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of NOX4 and NOX1 on immune cell-mediated inflammation in the aortic sinus of diabetic ApoE-/- mice.
Di Marco E; Gray SP; Chew P; Kennedy K; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Clin Sci (Lond); 2016 Aug; 130(15):1363-74. PubMed ID: 27190136
[TBL] [Abstract][Full Text] [Related]
19. IRE1α/NOX4 signaling pathway mediates ROS-dependent activation of hepatic stellate cells in NaAsO
Tao Y; Qiu T; Yao X; Jiang L; Wang N; Jiang J; Jia X; Wei S; Zhang J; Zhu Y; Tian W; Yang G; Liu X; Liu S; Ding Y; Sun X
J Cell Physiol; 2021 Feb; 236(2):1469-1480. PubMed ID: 32776539
[TBL] [Abstract][Full Text] [Related]
20. Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease.
Gray SP; Jha JC; Kennedy K; van Bommel E; Chew P; Szyndralewiez C; Touyz RM; Schmidt HHHW; Cooper ME; Jandeleit-Dahm KAM
Diabetologia; 2017 May; 60(5):927-937. PubMed ID: 28160092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
